AI-Driven Plasma Denaturation Profiling for Multi-Cancer Detection
Tsvetkov, P. O.; Eyraud, R.; Ayache, S.; Baksheeva, V.; Bertucci, A.; Mogenet, A.; Tomasini, P.; de Rauglaudre, B.; Dahan, L.; Gaudy-Marquestre, C.; Kalidindi, S. S. S.; Buffat, C.; Dehais, C.; Astier, A.; Ouafik, L.; Gorokhova, S.; Tabouret, E.; Devred, F.
Show abstract
Many cancers cannot be detected early due to lack of effective disease biomarkers, leading to poor prognosis. We applied an existing biophysical technology nanoDSF in a novel way to answer this unmet biomedical need. We developed a breakthrough digital biomarker method for cancer detection based on AI-classification of plasma denaturation profiles (PDPs) obtained by nanoDSF technology. PDPs from 300 plasma samples from patients with melanoma, brain, digestive or lung cancers were automatically distinguished from healthy profiles with an accuracy of 94%. Moreover, our method was able to distinguish different types of cancers from each other with an accuracy of 80%, making it an effective way to help cancer diagnosis and monitoring. Our technology thus paves the way for a long-sought multi-cancer early detection (MCED) test that is blood-based, cost-effective and easy-to-implement in any clinical setting.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Combi-Seq: Multiplexed transcriptome-based profiling of drug combinations using 1deterministic barcoding in single-cell droplets 93%
- Partner-independent fusion gene detection by multiplexed CRISPR/Cas9 enrichment and long-read Nanopore sequencing 93%
- NULISA: a novel proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing 93%
Similar papers in this journal
- Generalizing AI-driven Assessment of Immunohistochemistry across Immunostains and Cancer Types: A Universal Immunohistochemistry Analyzer 93%
- Mass spectrometry-based proteomics delivers in-depth proteome profiling of FFPE lung cancer biopsies from single glass slides 93%
- OnCorr: A pan-cancer mRNA-protein correlation tool for precision oncology 93%
Similar papers in this journal
Similar papers in this journal
- A flexible microfluidic system for single-cell transcriptome profiling elucidates phased transcriptional regulators of cell cycle 94%
- Molecular counting enables accurate and precise quantification of methylated ctDNA for tumor-naive cancer therapy response monitoring 93%
- Real-time SARS-CoV-2 diagnostic and variants tracking over multiple candidates using nanopore DNA sequencing 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.